Electrocardiogram in General Practice : the EGG Study (EGG)

June 19, 2023 updated by: Centre Hospitalier Universitaire de Saint Etienne

Existing resources to assist interpretation of ElectroCardioGram (ECG) in general practice provide specialized and comprehensive reading based on pathologies and ElectroCardioGram (ECG) signs rather than ElectroCardioGram (ECG) indications.

Describing practices in general medicine could help prioritize the relevance of clinical and ECG signs for the general practitioner, enabling to adjust the reading given the context.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

The primary objective of this study is to describe the clinical signs and ElectroCardioGram (ECG) in situations indicating an ElectroCardioGram (ECG) in general practice.

Study Type

Observational

Enrollment (Actual)

888

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Saint-Étienne, France
        • Association CNGE IRMG

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patient with indication of ElectroCardioGram (ECG) will be included.

Description

Inclusion Criteria:

  • Patient consulting one of the generalist practitioner investigators
  • In doctor's office or at home, scheduled or not,
  • During normal surgery hours or out-of-hours service,
  • Whatever the reason for consultation,
  • Aged 18 years or older,
  • Having an indication of ElectroCardioGram (ECG) and/or request certificate of non-contra-indication to the practice of physical activity certificate of non-contra-indication to the practice of physical activity

Exclusion Criteria:

  • ElectroCardioGram (ECG) not performed due to emergency context
  • Patient with cognitive impairment who cannot give consent to participate in the study and / or patient under guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patient with indication of ElectroCardioGram (ECG)
Patient with indication of ElectroCardioGram (ECG) will be included. They will have a collection of results ElectroCardioGram (ECG).
Diagnostic test: ElectroCardioGram (ECG)
Collection of results ElectroCardioGram (ECG).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of clinical signs
Time Frame: day 0
Prevalence of each clinical sign within each Electrocardiogram indication
day 0
Description of clinical signs ElectroCardioGram (ECG) sign
Time Frame: day 0
Prevalence of each sign on the Electrocardiogram within each indication.
day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difficulties in carrying out the Electrocardiogram
Time Frame: Day 0
Duration of the Electrocardiogram (minutes) Measured by average duration of the ECG, prevalence of the difficulties of realization and interpretation mentioned by the investigators.
Day 0
Initial management types
Time Frame: Months 1
Prevalence of initial management types (certificate, medication, addressing) at 1 month.
Months 1
Diagnosis types
Time Frame: Months 1
Prevalence of diagnosis types at 1 month.
Months 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Collaborators

Association CNGE IRMG

Investigators

  • Principal Investigator: Paul FRAPPE, MD, CHU de Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 17, 2019

Primary Completion (Actual)

October 1, 2021

Study Completion (Actual)

November 19, 2021

Study Registration Dates

First Submitted

November 18, 2019

First Submitted That Met QC Criteria

January 22, 2020

First Posted (Actual)

January 27, 2020

Study Record Updates

Last Update Posted (Actual)

June 22, 2023

Last Update Submitted That Met QC Criteria

June 19, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • IRBN432019/CHUSTE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Indication for ElectroCardioGram

Clinical Trials on ElectroCardioGram (ECG)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe